Touchstone Mid Cap Value Class A
TCVAX
NASDAQ
| Weiss Ratings | TCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Good | |||
| Risk Grade | B- | |||
| Company Info | TCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Touchstone | |||
| Manager/Tenure (Years) | R. Todd Vingers (11), Jay C. Willadsen (11) | |||
| Website | http://www.touchstoneinvestments.com | |||
| Fund Information | TCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Touchstone Mid Cap Value Class A | |||
| Category | Mid-Cap Value | |||
| Sub-Category | US Equity Mid Cap | |||
| Prospectus Objective | Growth | |||
| Inception Date | Sep 30, 2009 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 2,500.00 | |||
| Minimum Subsequent Investment | 50.00 | |||
| Front End Fee | 0.05 | |||
| Back End Fee | -- | |||
| Dividends and Shares | TCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.78% | |||
| Dividend | TCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.68% | |||
| Asset Allocation | TCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.81% | |||
| Stock | 99.19% | |||
| U.S. Stock | 98.43% | |||
| Non-U.S. Stock | 0.76% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | TCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.57% | |||
| 30-Day Total Return | -3.12% | |||
| 60-Day Total Return | -4.52% | |||
| 90-Day Total Return | -2.47% | |||
| Year to Date Total Return | 11.59% | |||
| 1-Year Total Return | 14.66% | |||
| 2-Year Total Return | 22.31% | |||
| 3-Year Total Return | 48.42% | |||
| 5-Year Total Return | 38.50% | |||
| Price | TCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | TCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $26.37 | |||
| 1-Month Low NAV | $25.93 | |||
| 1-Month High NAV | $27.39 | |||
| 52-Week Low NAV | $23.07 | |||
| 52-Week Low NAV (Date) | Oct 10, 2025 | |||
| 52-Week High NAV | $28.28 | |||
| 52-Week High Price (Date) | Aug 14, 2026 | |||
| Beta / Standard Deviation | TCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.74 | |||
| Standard Deviation | 13.61 | |||
| Balance Sheet | TCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 534.00M | |||
| Operating Ratios | TCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.17% | |||
| Turnover Ratio | 32.00% | |||
| Performance | TCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 29.38% | |||
| Last Bear Market Total Return | -12.22% | |||